Cordella Investigational device for Heart Failure patients
- Trial ID:
- IRB-21-7813
- Thomas Heywood, M.D.
Inclusion Criteria
Patients must:- Be at least 18 years of age
- Have been diagnosed with NYHA III heart failure and treated for more than 3 months
- Be on stable, optimally titrated medical therapy for at least 30 days
- Have had a heart failure hospitalization within 12 months
Exclusion Criteria
Patients must not:- Have a history of recurrent pulmonary embolism
- Have unrepaired severe valvular disease
- Have a history of life threatening allergy to contrast dye
Additional Info
- Study participants will receive the investigational Cordella PA Sensor System Implant. All treatments and physician visits will take place at Anderson Medical Pavilion. Follow-up visits will occur at 1, 3, 6, 12, 18, and 24 months and year 3 after the implant procedure.
- Search NCT # 04089059 @ Clinicaltrials.gov website
Contact Info:
- Clinical Research Leadership
- CRSLeadership@scrippshealth.org